Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Asthma
Interventions
DRUG

pioglitazone

pioglitazone tablets: 30 mg/day for 2 weeks; then increased to 45 mg/day until week 12 (approximately 3 months)

DRUG

placebo

matching placebo (inert tablet)

Trial Locations (2)

15213

University of Pittsburgh, Pittsburgh

05446

University of Vermont, Colchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

University of Vermont

OTHER

lead

Fernando Holguin

OTHER

NCT00634036 - Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics | Biotech Hunter | Biotech Hunter